Macrolide Antibiotics Market Revenue, Opportunity, Forecast and Value Chain Analysis 2019

16/ago/2019 08:53:02 Market Research Future Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.


Market Highlights

Macrolides such as azithromycin, clarithromycin, and erythromycin are a class of antibiotics that inhibit protein synthesis. It acts as a bacteriostatic agent against many strains of corynebacteria, listeria, moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp. It is used for the treatment of bacterial infections, such as nose, ear, and throat infections, chest infections, skin infections, as well as mouth and dental infections. They are also used as an alternative to penicillin.


The global macrolide antibiotic market is expected to show sharp growth over the globe. Rising prevalence of bacterial skin infections and rising number of dermatology clinics also favor the market growth. Macrolide antibiotics may increase the risk of sudden cardiac death, ventricular tachyarrhythmias, and cardiovascular death in patients, which may be the growth of the market over the assessment period.   

Request For Sample Report:




The data and information presented through more than 120 market data tables and figures spread over 200 pages of the project report. The in-depth table of content TOC & market synopsis on “macrolide antibiotics market research report - Global forecast till 2023.”


Major Players in Macrolide antibiotics Market

Merck Sharp & Dohme Corp (US), Pfizer Inc. (US), Neo Química (Brazil), Macrolide Pharmaceuticals (US), Teva Pharmaceutical Industries Ltd. (Israel), Fresenius Kabi USA (US), Sandoz International GmbH (Germany) , Gland Pharma Limited (India), Mylan NV (US), and WOCKHARDT (US)   


Regional Analysis

The global macrolide antibiotics market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.


The Americas dominates the global macrolide antibiotics market. It comprises of two regions namely North America and South America. The market in the American region is driven by the prescription of antibiotics in out-patient department in the US


In Europe, increasing use of azithromycin, and erythromycin has lead to rise in the demand for the macrolide antibiotics. France accounts for the largest market share


Asia Pacific is the fastest growing and potential market for the macrolide antibiotics whose growth is attributed to increasing awareness. Expansion of healthcare system in developing countries in Asia Pacific also favors the market growth.


Browse Complete Report:


The Middle East & Africa is expected to witness steady growth in this market.



The global macrolide antibiotics market is segmented on the basis of drugs, which includes azithromycin, clarithromycin, erythromycin, fidaxomicin, and telithromycin. On the basis of route of administration, the market is segmented into oral, parenteral. On the basis of indication, the market is segmented into infection due to mycoplasma pneumoniae, legionella sp, or bordetella pertussis, symptomatic cat-scratch disease, bacillary angiomatosis, peliosis hepatis in patients with AIDS, cerebral toxoplasmosis, uncomplicated skin infections, and others. On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmaceutical companies, and others.



Table Of Content:


1 Report Prologue


2 Market Introduction 

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations


3 Research Methodology 

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation


4 Market Dynamics 

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment


5. Market Factor Analysis 

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis


6. Global Macrolide Antibiotics Market, By Drug 

6.1 Introduction

6.2 Azithromycin

6.3 Clarithromycin

6.4 Erythromycin

6.5 Fidaxomicin

6.6 Telithromycin


7. Global Macrolide Antibiotics Market, By Route Of Administration 

7.1 Introduction

7.2 Infection Due To Mycoplasma Pneumonia, Legionella Sp, Or Bordetella Pertussis

7.3 Symptomatic Cat-Scratch Disease

7.4 Bacillary Angiomatosis

7.5 Peliosis Hepatis In Patients With AIDS

7.6 Cerebral Toxoplasmosis

7.7 Uncomplicated Skin Infections

7.8 Others

7.8.1 Babesiosis

7.8.2 Chlamydia Trachomatis Urethritis And Cervicitis


About Market Research Future: 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. 

MRFR team has the highest objective to provide optimal quality research and intelligence services to our clients. Our market research studies by Components, Applications, Logistics and market players for global, regional, and country level market segments, enable our clients to learn more, know more, and help their most important questions. 

MRFR often plans & conducts meet industry experts and industrial visits for its research analyst members. 


Market Research Future 

Office No. 528, Amanora Chambers 

Magarpatta Road, Hadapsar, 

Pune - 411028 

Maharashtra, India

+1 646 845 9312



blog comments powered by Disqus è un servizio offerto da Factotum Srl